Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
SAN CARLOS, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),..
SAN CARLOS, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),..
Washington, DC, May 17, 2024 (GLOBE NEWSWIRE) -- The Thurgood Marshall College Fund (TMCF) expresses its appreciation for the..
KK Invest, DBC Invest and Copenhagen Infrastructure Partners have entered into an agreement regarding the acquisition of the..